These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 19162152)
1. Solid state evaluation of some thalidomide raw materials. Carini JP; Pavei C; Silva AP; Machado G; Mexias AS; Pereira VP; Fialho SL; Mayorga P Int J Pharm; 2009 May; 372(1-2):17-23. PubMed ID: 19162152 [TBL] [Abstract][Full Text] [Related]
2. Solid-state characterization of rifampicin samples and its biopharmaceutic relevance. Agrawal S; Ashokraj Y; Bharatam PV; Pillai O; Panchagnula R Eur J Pharm Sci; 2004 Jun; 22(2-3):127-44. PubMed ID: 15158898 [TBL] [Abstract][Full Text] [Related]
3. Development and characterization of parenteral nanoemulsions containing thalidomide. Araújo FA; Kelmann RG; Araújo BV; Finatto RB; Teixeira HF; Koester LS Eur J Pharm Sci; 2011 Feb; 42(3):238-45. PubMed ID: 21130164 [TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process. Kim MS; Jin SJ; Kim JS; Park HJ; Song HS; Neubert RH; Hwang SJ Eur J Pharm Biopharm; 2008 Jun; 69(2):454-65. PubMed ID: 18359211 [TBL] [Abstract][Full Text] [Related]
5. Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour. Lai F; Sinico C; Ennas G; Marongiu F; Marongiu G; Fadda AM Int J Pharm; 2009 May; 373(1-2):124-32. PubMed ID: 19429297 [TBL] [Abstract][Full Text] [Related]
6. Identification of the mebendazole polymorphic form present in raw materials and tablets available in South Africa. Liebenberg W; Dekker TG; Lötter AP; de Villiers MM Drug Dev Ind Pharm; 1998 May; 24(5):485-8. PubMed ID: 9876612 [TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Hecq J; Deleers M; Fanara D; Vranckx H; Amighi K Int J Pharm; 2005 Aug; 299(1-2):167-77. PubMed ID: 15996838 [TBL] [Abstract][Full Text] [Related]
8. Developing a discriminating dissolution test for three mebendazole polymorphs based on solubility differences. Swanepoel E; Liebenberg W; Devarakonda B; de Villiers MM Pharmazie; 2003 Feb; 58(2):117-21. PubMed ID: 12641328 [TBL] [Abstract][Full Text] [Related]
9. Polymorph screening of an active material. Láng P; Kiss V; Ambrus R; Farkas G; Szabó-Révész P; Aigner Z; Várkonyi E J Pharm Biomed Anal; 2013 Oct; 84():177-83. PubMed ID: 23845379 [TBL] [Abstract][Full Text] [Related]
10. Cefdinir: A comparative study of anhydrous vs. monohydrate form. Microstructure and tabletting behaviour. Cabri W; Ghetti P; Alpegiani M; Pozzi G; Justo-Erbez A; Pérez-Martínez JI; Villalón-Rubio R; Monedero-Perales MC; Muñoz-Ruiz A Eur J Pharm Biopharm; 2006 Oct; 64(2):212-21. PubMed ID: 16846727 [TBL] [Abstract][Full Text] [Related]
11. Studies on the crystalline form of phenytoin. Chakrabarti S; van Severen R; Braeckman P Pharmazie; 1978 Jun; 33(6):338-9. PubMed ID: 684047 [TBL] [Abstract][Full Text] [Related]
12. Solid-state evaluation and polymorphic quantification of venlafaxine hydrochloride raw materials using the Rietveld method. Bernardi LS; Ferreira FF; Cuffini SL; Campos CE; Monti GA; Kuminek G; Oliveira PR; Cardoso SG Talanta; 2013 Dec; 117():189-95. PubMed ID: 24209329 [TBL] [Abstract][Full Text] [Related]
13. Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy. Savolainen M; Kogermann K; Heinz A; Aaltonen J; Peltonen L; Strachan C; Yliruusi J Eur J Pharm Biopharm; 2009 Jan; 71(1):71-9. PubMed ID: 18590816 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of melt granulation and ultrasonic spray congealing as techniques to enhance the dissolution of praziquantel. Passerini N; Albertini B; Perissutti B; Rodriguez L Int J Pharm; 2006 Aug; 318(1-2):92-102. PubMed ID: 16697539 [TBL] [Abstract][Full Text] [Related]
15. Dissolution rate of furosemide from polyethylene glycol solid dispersions. Ozdemir N; Ordu S Farmaco; 1997 Oct; 52(10):625-9. PubMed ID: 9507675 [TBL] [Abstract][Full Text] [Related]
16. Solubility and intrinsic dissolution rate of alprazolam crystal modifications. Laihanen N; Muttonen E; Laaksonen M Pharm Dev Technol; 1996 Dec; 1(4):373-80. PubMed ID: 9552321 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach. Mutalik S; Anju P; Manoj K; Usha AN Int J Pharm; 2008 Feb; 350(1-2):279-90. PubMed ID: 17945447 [TBL] [Abstract][Full Text] [Related]
18. [X-ray diffractometry in the analysis of drugs and pharmaceutical forms]. Bettinetti GP Boll Chim Farm; 1989 May; 128(5):149-62. PubMed ID: 2690894 [TBL] [Abstract][Full Text] [Related]
19. Hydrate modifications of the non-steroidal anti-inflammatory drug diclofenac sodium: Solid-state characterisation of a trihydrate form. Bartolomei M; Rodomonte A; Antoniella E; Minelli G; Bertocchi P J Pharm Biomed Anal; 2007 Nov; 45(3):443-9. PubMed ID: 17709225 [TBL] [Abstract][Full Text] [Related]
20. Study of process induced polymorphic transformations in fluconazole drug. Desai SR; Dharwadkar SR Acta Pol Pharm; 2009; 66(2):115-22. PubMed ID: 19719043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]